These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21268919)

  • 21. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
    Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
    Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
    Arpaci D; Karakas Celik S; Can M; Ermiş E; Kuzu F; Kokturk F; Hamamcioglu AC; Dursun A; Bayraktaroglu T
    Redox Rep; 2016 Nov; 21(6):281-6. PubMed ID: 26863932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Hama SY; Bourquard N; Navab M; Reddy ST
    Mol Genet Metab; 2006 Dec; 89(4):368-73. PubMed ID: 16935014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
    Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The paraoxonase gene polymorphism in stroke patients and lipid profile.
    Shin BS; Oh SY; Kim YS; Kim KW
    Acta Neurol Scand; 2008 Apr; 117(4):237-43. PubMed ID: 17854416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in paraoxonase-1 activity and atherosclerosis.
    Soran H; Younis NN; Charlton-Menys V; Durrington P
    Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paraoxonase gene family and atherosclerosis.
    Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST
    Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase gene polymorphisms, oxidative stress, and diseases.
    Li HL; Liu DP; Liang CC
    J Mol Med (Berl); 2003 Dec; 81(12):766-79. PubMed ID: 14551701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?
    Reddy ST; Devarajan A; Bourquard N; Shih D; Fogelman AM
    Curr Opin Lipidol; 2008 Aug; 19(4):405-8. PubMed ID: 18607188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
    Paragh G; Törocsik D; Seres I; Harangi M; Illyés L; Balogh Z; Kovács P
    Curr Med Res Opin; 2004 Aug; 20(8):1321-7. PubMed ID: 15324535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
    Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
    Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress.
    Calla MS; Lynch SM
    Arch Biochem Biophys; 2006 Aug; 452(2):129-37. PubMed ID: 16854368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.